1. Market Research
  2. > Healthcare
  3. > Pathology
  4. > Chronic Disease Market Trends

Preventive Asthma Drug Market Outlook 2020

  • December 2015
  • 50 pages
  • RNCOS
Report ID: 3472832

Summary

Table of Contents

Asthma is showing high prevalence worldwide. About 300 Million people are suffering from asthma. This is due to continuously deteriorating air quality, which is causing several allergies. In recent years, researchers have explored wide variety of preventive drugs that can delay asthma attacks. These drugs are being highly acknowledged by the doctors and consumers. The practice of prescribing preventive drugs by doctors is gaining momentum in the US, Europe and Asia-Pacific. Foreseeing the demand, several pharma players are shifting their R&D focus towards preventive asthma drugs. Some of the leading players in the pharma industry include Glaxosmithkline, Astrazeneca, Merck, Novartis, Roche, and others. The drugs by these players contributed millions of dollars to their revenue in 2014.

In its latest research, “Preventive Asthma Drug Market Outlook 2020”, RNCOS presents a comprehensive analysis of the industry. The report covers key drivers & challenges, and trends & developments that are peculiar to the drug market. The research includes estimated market figures of 2014, and forecasted numbers till 2020. The market was estimated at US$ 22 Billion in 2014. Our analysts have segmented the preventive asthma drug industry depending on the type of drugs and geographical distribution. A separate section is allotted to the competitive landscape, including the business overview of the key players and their SWOT analysis.

Our research revealed that inhaled corticosteroids were the most popular category of preventers during 2014. Researchers are combining corticosteroids with other form of drugs, such as long acting beta agonists in a single inhaler. The so called “combination therapy” is providing several benefits over the single dose. However, the market is facing few challenges like side-effects posed by such drugs, their high cost and lack of awareness in India, China, and other Middle East & Asia-Pacific countries.

Towards the end, RNCOS has suggested some recommendations to boost the preventers market in the coming future. On the whole, the research contains exhaustive information that will help clients in formulating market strategies and assessing opportunity areas in the preventive asthma drugs industry.

Get Industry Insights. Simply.

  • Latest reports & slideshows with insights from top research analysts
  • 60 Million searchable statistics with tables, figures & datasets
  • More than 25,000 trusted sources
  • Single User License — provides access to the report by one individual.
  • Department License — allows you to share the report with up to 5 users
  • Site License — allows the report to be shared amongst all employees in a defined country
  • Corporate License — allows for complete access, globally.

Ahmad helps you find the right report:

Testimonials

The research specialist advised us on the best content for our needs and provided a great report and follow-up, thanks very much we shall look at ReportLinker in the future.

Kate Merrick

Global Marketing Manager at
Eurotherm by Schneider Electric

We were impressed with the support that ReportLinker’s research specialists’ team provided. The report we purchased was useful and provided exactly what we want.

Category Manager at
Ikea

ReportLinker gave access to reliable and useful data while avoiding dispersing resources and spending too much time on unnecessary research.

Executive Director at
PwC Advisory

The customer service was fast, responsive, and 100% professional in all my dealings (...) If we have more research needs, I'll certainly prioritize working with ReportLinker!

Scott Griffith

Vice President Marketing at
Maurice Sporting Goods

The research specialist provided prompt, helpful instructions for accessing ReportLinker's product. He also followed up to make sure everything went smoothly and to ensure an easy transition to the next stage of my research

Jessica P Huffman

Research Associate at
American Transportation Research Institute

Excellent customer service. Very responsive and fast.

Director, Corporate Strategy at
Ingredion

I reached out to ReportLinker for a detailed market study on the Air Treatment industry. The quality of the report, the research specialist’s willingness to solve my queries exceeded my expectations. I would definitely recommend ReportLinker for in-depth industry information.

Mariana Mendoza

Global Platform Senior Manager at
Whirlpool Corporation

Thanks! I like what you've provided and will certainly come back if I need to do further research works.

Bee Hin Png

CEO at
LDR Pte Ltd

The research specialist advised us on the best content for our needs and provided a great report and follow-up, thanks very much we shall look at ReportLinker in the future.

Kate Merrick

Global Marketing Manager at
Eurotherm by Schneider Electric

Purchase Reports From Reputable Market Research Publishers

Asthma Therapeutics in Asia-Pacific Markets to 2023 - High Prevalence and Highly Priced Existing & Upcoming Biologics will Drive the Market

  • $ 4995
  • Industry report
  • June 2017
  • by GBI Research

Asthma Therapeutics in Asia-Pacific Markets to 2023 - High Prevalence and Highly Priced Existing & Upcoming Biologics will Drive the Market Summary Asthma is a common chronic inflammatory disease of the ...

EpiCast Report: Chronic Obstructive Pulmonary Disease - Epidemiology Forecasts to 2025

  • $ 3995
  • Industry report
  • July 2017
  • by GlobalData

EpiCast Report: Chronic Obstructive Pulmonary Disease - Epidemiology Forecasts to 2025 Summary Chronic obstructive pulmonary disease (COPD), also known as chronic obstructive lung disease (COLD), is a ...

Chronic Asthma Global Clinical Trials Review, H1, 2017

  • $ 2500
  • Industry report
  • June 2017
  • by GlobalData

Chronic Asthma Global Clinical Trials Review, H1, 2017 Summary GlobalData’s clinical trial report, “Chronic Asthma Global Clinical Trials Review, H1, 2017" provides an overview of Chronic Asthma clinical ...


Download Unlimited Documents from Trusted Public Sources

Vaccine Market and Influenza Statistics in India

  • September 2017
    6 pages
  • Vaccine  

    Influenza  

    Diabetes  

  • India  

    United States  

View report >

Chronic Disease Statistics in Europe - Forecast

  • September 2017
    9 pages
  • Chronic Disease  

    Renal Disease  

  • Europe  

    United Kingdom  

View report >

Hypertension Statistics in the US

  • September 2017
    14 pages
  • Hypertension  

  • United States  

    North America  

View report >

Related Market Segments :

Asthma

ref:plp2015

Reportlinker.com © Copyright 2017. All rights reserved.

ReportLinker simplifies how Analysts and Decision Makers get industry data for their business.